Is Thermo Fisher Scientific Inc. overvalued?

Thermo Fisher Scientific Inc. (TMO) looks overvalued — trading about 22% above its fair value.

Overvalued

Price

$700.22

Fair value

$547.05

Current P/E

39.5

Normal P/E

30.8

Market cap

$259.44B

Dividend yield

0.3%

Return on equity

13.3%

Sector

Healthcare

Fair value compares TMO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks